Christian Kersten,Marte Grønlie Cameron,Svein Mjåland
申请号：
US16824108
公开号：
US20200216547A1
申请日:
2020.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain. The invention relates in more detail to compositions comprising inhibitors of EGFR
